Loading…
Taysha Gene Therapies, Inc. is projected to rise to $7.96 by 2027, a +26% move from its current price of $6.34. TSHA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/13/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $6.15 | $6.35 | $6.55 | +0.09% |
| Jul 15 | $6.07 | $6.35 | $6.64 | +0.18% |
| Jul 16 | $6.02 | $6.36 | $6.72 | +0.27% |
| Jul 17 | $5.97 | $6.36 | $6.78 | +0.36% |
| Jul 18 | $5.93 | $6.37 | $6.84 | +0.45% |
| Jul 19 | $5.90 | $6.37 | $6.89 | +0.55% |
| Jul 20 | $5.87 | $6.38 | $6.94 | +0.64% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.87 | $6.38 | $6.94 | +0.64% |
| Week 2 | $5.70 | $6.42 | $7.23 | +1.28% |
| Week 3 | $5.59 | $6.46 | $7.47 | +1.92% |
| Week 4 | $5.50 | $6.50 | $7.69 | +2.57% |
| Week 5 | $5.43 | $6.54 | $7.89 | +3.23% |
| Week 6 | $5.36 | $6.59 | $8.09 | +3.88% |
| Week 7 | $5.31 | $6.63 | $8.27 | +4.54% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Taysha Gene Therapies, Inc. (TSHA) is a clinical-stage biotechnology company focused on developing and commercializing adeno-associated virus-based gene therapies for severe monogenic diseases of the central nervous system.
The company is developing TSHA-120 for giant axonal neuropathy; TSHA-102 for Rett syndrome; TSHA-121 for CLN7 disease; TSHA-118 for CLN1 disease; TSHA-105 for SLC13A5 deficiency; TSHA-113 for tauopathies; TSHA-106 for Angelman syndrome; and TSHA-114 for fragile X syndrome.
Taysha Gene Therapies, Inc. was incorporated in 2019 and is headquartered in Dallas, Texas. It has a research, collaboration, and license agreement with The University of Texas Southwestern Medical Center.
The stock is currently priced at $6.73 and has a market cap of $1.93B. Its rank is 1972. The current price aligns with a 2026 forecast that shows a min of $4.07, an average of $6.73, and a max of $9.91, with a NEUTRAL sentiment.
From 2027 onward, the forecast envisions a bullish trajectory, with the average price rising to $8.25 in 2027, $9.01 in 2028, and $16.48 on average in 2030, ultimately reaching $132.33 on average by 2050. The ROIs expand across years, with 22.6% in 2027, 33.8% in 2028, 93.5% in 2029, 144.9% in 2030, 182.4% in 2031, 233.4% in 2032, 232.1% in 2033, 270.6% in 2034, 322.5% in 2035, 631.1% in 2040, and 1866.2% by 2050.
A major floor 35.8% below — a decisive break under it would weaken the trend.
The nearest floor, 15.5% below — buyers have tended to step in here.
The nearest ceiling, 9.5% above — a clean break opens room to run.
A major ceiling 22.9% above — clearing it would confirm fresh momentum.
Key TSHA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TSHA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.46 | Sell | $6.47 | Sell |
| MA 10 | $6.53 | Sell | $6.47 | Sell |
| MA 20 | $6.38 | Sell | $6.36 | Sell |
| MA 50 | $6.17 | Buy | $6.08 | Buy |
| MA 100 | $5.53 | Buy | $5.69 | Buy |
| MA 200 | $5.13 | Buy | $5.05 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 51.04 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -9.36 | Neutral |
| Williams %R (14) | -82.19 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -7.58 | Sell |
| Bollinger %B (20,2) | 0.47 | Neutral |
| Stochastic %K (14) | 17.81 | Buy |
| TRIX (15) | 0.42 | Buy |
| Awesome (5,34) | 0.38 | Buy |
| Ultimate (7,14,28) | 34.77 | Neutral |
| Momentum (10) | 0.13 | Buy |
| Aroon Osc (25) | 40.00 | Buy |
| Hull MA (9) | 6.44 | Sell |
| ADX (14) | 13.99 | Neutral |
| ATR (14) | 0.18 | Info |
The 30-day technical picture is bullish. RSI14 is 60, with a SMA50 of $6.15 and a SMA200 of $4.99. Short-term support sits at $5.18, with resistance at $6.94. The 30-day range spans $5.24 to $8.65, and annualized volatility is 70%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.07 | $6.34 | $9.09 | 0% | Neutral | |
| $6.24 | $7.96 | $10.79 | +26% | Bullish | |
| $6.47 | $8.52 | $12.04 | +34% | Bullish | |
| $8.83 | $11.95 | $17.46 | +89% | Bullish | |
| $10.92 | $15.16 | $22.76 | +139% | Bullish | |
| $12.19 | $17.30 | $26.60 | +173% | Bullish | |
| $14.07 | $20.38 | $32.01 | +221% | Bullish | |
| $14.18 | $20.94 | $33.53 | +230% | Bullish | |
| $15.33 | $23.08 | $37.61 | +264% | Bullish | |
| $17.16 | $26.29 | $43.56 | +315% | Bullish | |
| $26.72 | $44.44 | $78.84 | +601% | Bullish | |
| $61.42 | $117.98 | $231.10 | +17.6x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $4.07 | $6.34 | $7.61 | +0.00% |
| August 2026 | $5.63 | $6.67 | $8.13 | +5.21% |
| September 2026 | $5.76 | $6.89 | $8.51 | +3.25% |
| October 2026 | $5.67 | $6.82 | $8.52 | -0.94% |
| November 2026 | $5.71 | $6.91 | $8.71 | +1.32% |
| December 2026 | $5.87 | $7.15 | $9.09 | +3.46% |
Click any year to see its month-by-month TSHA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, TSHA could reach as high as $9.09, with a base case around $6.34 and support toward $4.07 — roughly 0% from $6.34. A consolidation phase looks the most probable path here.
Expect TSHA to range from $6.24 to $10.79 through 2027. The $7.96 average target implies a +26% move from current prices. That is up +26% on the projected 2026 average. Momentum favours further upside here.
The TSHA price prediction for 2028 points to an average of $8.52 (low $6.47, high $12.04) — a potential gain of +34% on today's $6.34. Buyers look set to stay in control over this stretch.
In 2029, TSHA is projected to trade between $8.83 and $17.46, averaging $11.95 — a potential gain of +89% from today's $6.34. That is up +40% on the projected 2028 average. Momentum favours further upside here.
Taysha Gene Therapies, Inc.'s 2030 outlook centres on $15.16, within a $10.92 to $22.76 range. That is up +27% on the projected 2029 average. That marks a +139% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, TSHA could reach as high as $26.60, with a base case around $17.30 and support toward $12.19 — roughly +173% from $6.34. Momentum favours further upside here.
Expect TSHA to range from $14.07 to $32.01 through 2032. The $20.38 average target implies a +221% move from current prices. That is up +18% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The TSHA price prediction for 2033 points to an average of $20.94 (low $14.18, high $33.53) — a potential gain of +230% on today's $6.34. Momentum favours further upside here.
In 2034, TSHA is projected to trade between $15.33 and $37.61, averaging $23.08 — a potential gain of +264% from today's $6.34. That is up +10% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Taysha Gene Therapies, Inc.'s 2035 outlook centres on $26.29, within a $17.16 to $43.56 range. That is up +14% on the projected 2034 average. That marks a +315% change versus current levels. Momentum favours further upside here.
By 2040, TSHA could reach as high as $78.84, with a base case around $44.44 and support toward $26.72 — roughly +601% from $6.34. Buyers look set to stay in control over this stretch.
Expect TSHA to range from $61.42 to $231.10 through 2050. The $117.98 average target implies a +17.6x move from current prices. That is up +166% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in TSHA today (≈ 157.728707 TSHA) could be worth
$18,609.28
+$17,609.28 (+1761%) by 2050 · US Dollar
Based on the average projected TSHA price of $117.98 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TSHAwould be worth at today's price.
$1,000 invested in TSHA on Jul 10, 2025 (≈ 392.15687 TSHA) would be worth
$2,486.27
+$1,486.27 (+148.6%) today · 2.49× · US Dollar
Based on a TSHA entry price of $2.55 vs. today's $6.34.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $6.53 | $970.9 | -2.9% |
| 1 month ago | $5.4 | $1,174.07 | +17.4% |
| 3 months ago | $4.49 | $1,412.03 | +41.2% |
| 6 months ago | $4.86 | $1,304.53 | +30.5% |
| 1 year ago | $2.55 | $2,486.27 | +148.6% |
| All time (5.0y) ago | $20.5 | $309.27 | -69.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TSHA forecast.
Our base-case forecast reaches $13.00 around 2030.
Implied market cap at $13.00: $3.74B
In the multi-year forecast, 2026 shows min $4.07, avg $6.73, max $9.91 with NEUTRAL sentiment.
From 2027 onward, the averages rise: $8.25 in 2027, $9.01 in 2028, $13.02 in 2029, $16.48 in 2030, $19.01 in 2031, $22.44 in 2032, $22.35 in 2033, $24.94 in 2034, and $28.44 in 2035. These years carry bullish sentiment with ROIs ranging from 22.6% to 322.5%.
The forecast projects $49.20 as the 2040 average (max $93.39) with a 631.1% ROI, and $132.33 as the 2050 average (max $280.44) with a 1866.2% ROI. The outlook remains bullish across the long horizon, but these are estimates, not guarantees.
Tap a question to reveal the answer.
According to the forecast, TSHA could average $16.48 in 2030, with a min of $11.37 and a max of $25.89, and an estimated ROI of 144.9%; sentiment is BULLISH.
The forecast shows a bullish trajectory across multiple years with rising average prices and ROIs up to 1866.2% by 2050; these are estimates, not guarantees.
The 2040 max is $93.39 and the 2050 max is $280.44, so reaching above $100 is possible by 2050 according to the forecast.
$1.93B.
Taysha Gene Therapies, Inc. Community Discussion
0Share your Taysha Gene Therapies, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.